These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31479535)

  • 1. Behaviour change, weight loss and remission of Type 2 diabetes: a community-based prospective cohort study.
    Dambha-Miller H; Day AJ; Strelitz J; Irving G; Griffin SJ
    Diabet Med; 2020 Apr; 37(4):681-688. PubMed ID: 31479535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of an intensive lifestyle intervention with remission of type 2 diabetes.
    Gregg EW; Chen H; Wagenknecht LE; Clark JM; Delahanty LM; Bantle J; Pownall HJ; Johnson KC; Safford MM; Kitabchi AE; Pi-Sunyer FX; Wing RR; Bertoni AG;
    JAMA; 2012 Dec; 308(23):2489-96. PubMed ID: 23288372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of cardiovascular disease risk by health behaviour change following type 2 diabetes diagnosis.
    Estlin AFL; Ahern AL; Griffin SJ; Strelitz J
    Diabet Med; 2021 Oct; 38(10):e14646. PubMed ID: 34270827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-year weight change after diabetes diagnosis and long-term incidence and sustainability of remission of type 2 diabetes in real-world settings in Hong Kong: An observational cohort study.
    Wu H; Yang A; Lau ESH; Zhang X; Fan B; Ma RCW; Kong APS; Chow E; So WY; Chan JCN; Luk AOY
    PLoS Med; 2024 Jan; 21(1):e1004327. PubMed ID: 38261560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial.
    Taheri S; Zaghloul H; Chagoury O; Elhadad S; Ahmed SH; El Khatib N; Amona RA; El Nahas K; Suleiman N; Alnaama A; Al-Hamaq A; Charlson M; Wells MT; Al-Abdulla S; Abou-Samra AB
    Lancet Diabetes Endocrinol; 2020 Jun; 8(6):477-489. PubMed ID: 32445735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial.
    Lean MEJ; Leslie WS; Barnes AC; Brosnahan N; Thom G; McCombie L; Peters C; Zhyzhneuskaya S; Al-Mrabeh A; Hollingsworth KG; Rodrigues AM; Rehackova L; Adamson AJ; Sniehotta FF; Mathers JC; Ross HM; McIlvenna Y; Welsh P; Kean S; Ford I; McConnachie A; Messow CM; Sattar N; Taylor R
    Lancet Diabetes Endocrinol; 2019 May; 7(5):344-355. PubMed ID: 30852132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in behaviors after diagnosis of type 2 diabetes and 10-year incidence of cardiovascular disease and mortality.
    Strelitz J; Ahern AL; Long GH; Boothby CE; Wareham NJ; Griffin SJ
    Cardiovasc Diabetol; 2019 Aug; 18(1):98. PubMed ID: 31370851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in diet, cardiovascular risk factors and modelled cardiovascular risk following diagnosis of diabetes: 1-year results from the ADDITION-Cambridge trial cohort.
    Savory LA; Griffin SJ; Williams KM; Prevost AT; Kinmonth AL; Wareham NJ; Simmons RK
    Diabet Med; 2014 Feb; 31(2):148-55. PubMed ID: 24102972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of type 2 diabetes remission in Scotland in 2019: A cross-sectional population-based study.
    Captieux M; Fleetwood K; Kennon B; Sattar N; Lindsay R; Guthrie B; Wild SH;
    PLoS Med; 2021 Nov; 18(11):e1003828. PubMed ID: 34727107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of change in objectively measured and self-reported health behaviours among individuals with recently diagnosed type 2 diabetes: longitudinal results from the ADDITION-Plus trial cohort.
    Kuznetsov L; Simmons RK; Sutton S; Kinmonth AL; Griffin SJ; Hardeman W;
    Int J Behav Nutr Phys Act; 2013 Oct; 10():118. PubMed ID: 24152757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate weight change following diabetes diagnosis and 10 year incidence of cardiovascular disease and mortality.
    Strelitz J; Ahern AL; Long GH; Hare MJL; Irving G; Boothby CE; Wareham NJ; Griffin SJ
    Diabetologia; 2019 Aug; 62(8):1391-1402. PubMed ID: 31062041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple behaviour change intervention and outcomes in recently diagnosed type 2 diabetes: the ADDITION-Plus randomised controlled trial.
    Griffin SJ; Simmons RK; Prevost AT; Williams KM; Hardeman W; Sutton S; Brage S; Ekelund U; Parker RA; Wareham NJ; Kinmonth AL;
    Diabetologia; 2014 Jul; 57(7):1308-19. PubMed ID: 24759957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of type 2 diabetes and remission rates after bariatric surgery in Sweden 2007-2015: A registry-based cohort study.
    Jans A; Näslund I; Ottosson J; Szabo E; Näslund E; Stenberg E
    PLoS Med; 2019 Nov; 16(11):e1002985. PubMed ID: 31747392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 diabetes remission 1 year after an intensive lifestyle intervention: A secondary analysis of a randomized clinical trial.
    Ried-Larsen M; Johansen MY; MacDonald CS; Hansen KB; Christensen R; Wedell-Neergaard AS; Pilmark NS; Langberg H; Vaag AA; Pedersen BK; Karstoft K
    Diabetes Obes Metab; 2019 Oct; 21(10):2257-2266. PubMed ID: 31168922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Change in Physiological Markers and Cognitive Performance in Type 2 Diabetes: The Look AHEAD Study.
    Carmichael OT; Neiberg RH; Dutton GR; Hayden KM; Horton E; Pi-Sunyer FX; Johnson KC; Rapp SR; Spira AP; Espeland MA
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4778-91. PubMed ID: 32845968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary care experience and remission of type 2 diabetes: a population-based prospective cohort study.
    Dambha-Miller H; Day A; Kinmonth AL; Griffin SJ
    Fam Pract; 2021 Mar; 38(2):141-146. PubMed ID: 32918549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthy behavior change and cardiovascular outcomes in newly diagnosed type 2 diabetic patients: a cohort analysis of the ADDITION-Cambridge study.
    Long GH; Cooper AJ; Wareham NJ; Griffin SJ; Simmons RK
    Diabetes Care; 2014 Jun; 37(6):1712-20. PubMed ID: 24658389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial.
    Dixon JB; O'Brien PE; Playfair J; Chapman L; Schachter LM; Skinner S; Proietto J; Bailey M; Anderson M
    JAMA; 2008 Jan; 299(3):316-23. PubMed ID: 18212316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Diabetes Remission in India (DiRemI) study: Protocol for a prospective matched-control trial.
    Tripathi P; Kadam N; Tiwari D; Kathrikolly T; Vyawahare A; Sharma B; Ganla M; Saboo B
    PLoS One; 2024; 19(6):e0306394. PubMed ID: 38941311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT).
    Thom G; Messow CM; Leslie WS; Barnes AC; Brosnahan N; McCombie L; Al-Mrabeh A; Zhyzhneuskaya S; Welsh P; Sattar N; Taylor R; Lean MEJ
    Diabet Med; 2021 Aug; 38(8):e14395. PubMed ID: 32870520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.